Vascular Performance Protocol
PDE5 inhibitor protocols evaluated by independent licensed providers. Many evaluations are conducted through secure online intake; some states or clinical situations require a video evaluation or in-person follow-up. Your provider will advise if that applies to your case.
Three Steps to Clinical Intake
The ForgeVita platform routes your intake to an independent licensed clinical practice in your state. Here's what to expect.
Start Assessment
Complete your 5-minute health intake at no cost. Your state is verified for routing availability before any clinical workflow begins.
Clinical Matching
The secure clinical partner workflow discloses the independent provider entity, applicable consents, and all charges before your evaluation begins.
Receive If Prescribed
If treatment is clinically approved by the independent provider, the pharmacy partner fulfills and ships your medication in plain, unbranded packaging.
Understanding ED
Clinical context for patients researching PDE5 inhibitor therapy.
Erectile dysfunction (ED) is the persistent inability to achieve or maintain an erection sufficient for satisfactory sexual activity. It is one of the most prevalent conditions affecting adult men, with estimates suggesting tens of millions of men in the United States experience ED to some degree.
ED can have vascular, neurological, hormonal, and psychological components — or a combination of these. Age is a significant risk factor, though ED is not an inevitable consequence of aging. Comorbidities such as hypertension, diabetes, hyperlipidemia, and cardiovascular disease are frequently associated with ED, which is why a thorough clinical evaluation is important.
PDE5 inhibitors are the most widely prescribed and clinically studied first-line pharmacological treatment option for ED. These agents work by inhibiting phosphodiesterase type 5, relaxing smooth muscle in penile vasculature and increasing blood flow in response to sexual stimulation. Sexual stimulation is required — these medications do not cause spontaneous erections.
Evaluation by an independent licensed provider is required to determine clinical appropriateness, screen for contraindications (particularly with nitrate-containing cardiac medications), and establish a care plan. ForgeVita does not prescribe, evaluate, or provide any clinical services.
PDE5 Inhibitor Medications
The independent licensed provider evaluates which option is most appropriate for your individual health profile, history, and clinical circumstances.
Sildenafil
Generic sildenafil (the active compound in Viagra). Typically taken on-demand 30–60 minutes before sexual activity. Duration approximately 4–6 hours.
Tadalafil
Generic tadalafil (the active compound in Cialis). Available as a daily low-dose option or on-demand use. Longer duration of action — up to 36 hours.
Vardenafil / Avanafil
Alternative PDE5 inhibitor options. Avanafil has a faster onset profile. Provider evaluates based on your complete health history and individual clinical considerations.
Compounded / Combination
In select clinical situations, your independent provider may prescribe a compounded formulation through a 503A compounding pharmacy when a commercially available product is not appropriate for your individual medical needs. Compounded formulations are not FDA-approved and are available only by patient-specific prescription based on your provider's assessment of medical necessity. Compounded options are not available as a consumer-choice alternative to FDA-approved formulations.
If compounded, sublingual, orally dissolving, or combination formulations are offered, they will be clearly identified as compounded, and availability may vary by state, pharmacy, and provider judgment.
Frequently Asked Questions
Transparency about process, cost, privacy, and what to expect.
Is the process private?
How much does it cost?
Are PDE5 inhibitors safe?
Do I need a video visit?
What if I have a heart condition?
Which states is this available in?
Explore Other Programs
Additional clinical protocols available through the ForgeVita platform.
Ready to Begin Your Assessment?
Complete the 5-minute intake. State availability is verified during the process. No payment required to start.
Start AssessmentCompounded Formulations: Compounded PDE5 formulations are not FDA-approved as equivalents to commercially available products. Compounded preparations are prepared by 503A compounding pharmacies by patient-specific prescription only, based on the independent licensed provider's assessment that a commercially available product is not clinically appropriate for the individual patient's medical needs. Compounded options are not available as a consumer-choice alternative to FDA-approved formulations. Commercially available sildenafil and tadalafil are not currently on the FDA drug shortage list.